ZKB/PUT/ROCHE GS/210/0.025/06.01.25 Share Price

Warrant

ROG68Z

CH1305148681

Real-time Bid/Ask 11:29:39 24/06/2024 BST
0.05 CHF / 0.06 CHF -15.38% Intraday chart for ZKB/PUT/ROCHE GS/210/0.025/06.01.25
Current month-53.57%
1 month-50.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
20/06/24 0.065 -7.14%
19/06/24 0.07 -6.67%
18/06/24 0.075 -6.25%

Delayed Quote Swiss Exchange

Last update June 20, 2024 at 04:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
Issuer ZKB
ROG68Z
ISINCH1305148681
Date issued 25/03/2024
Strike 210 CHF
Maturity 06/01/2025 (196 Days)
Parity 40 : 1
Emission price 0.19 CHF
Emission volume N/A
Settlement les deux
Currency CHF

Technical Indicators

Highest since issue 0.27 CHF
Lowest since issue 0.065 CHF
Delta-0.1x
Omega 11.91
Premium17.8x
Gearing114.91x
Moneyness 0.8307
Difference Strike -44 CHF
Difference Strike %-20.95%
Spread 0.01 CHF
Spread %16.67%
Theoretical value 0.0550
Implied Volatility 22.43 %
Total Loss Probability 86.38 %
Intrinsic value 0.000000
Present value 0.0550
Break even 207.80 CHF
Theta-0x
Vega0.01x
Rho-0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
252.8 CHF
Average target price
278.1 CHF
Spread / Average Target
+9.99%
Consensus
  1. Stock Market
  2. Warrants
  3. ROG68Z Warrant